Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: Mid-term outcomes from a tertiary medical center

Journal of Invasive Cardiology

Volumn 21, Issue 7, 2009, Pages 321-325

  Shammas, Nicolas W ^a,b   Shammas, Gail A ^a   Jerin, Michael ^a   Parikh, Anup ^a   Coin, Katherine ^a   Dippel, Eric ^a   Sharis, Peter ^a   Robken, Jon ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b Cardiovascular Medicine Davenport   (United States)

Author keywords

Left main; Paclitaxel eluting stent; Thrombosis; Trifurcation stent

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; CORONARY ARTERY ANOMALY; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT MAIN CORONARY ARTERY TRIFURCATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; OUTCOME VARIABLE; STENT THROMBOSIS; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG EFFECTS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PACLITAXEL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 68049103137     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lindsey RL Jr, Saporito J, Kleist PC, Kalash Y. Triple balloon-on-a-wire or "menage à trois" coronary angioplasty. Cathet Cardiovasc Diagn 1993;28:76-79.
2. Colombo A. Case Studies - 2002 - October 2002 - LMCA trifurcation stenosis treated with Cypher stents and GP IIb/IIIa inhibitor with subsequent acute LAD occlusion and repeat intervention. Presented at TCTMD.com
3. Colombo A. Case Studies - 2001 - Trifurcation stenting using rapamycin-coated stents with follow-up. Presented at TCTMD.com
4. Hong M-K, Marchment J. Case Studies - 2004 - July 2004 - Left anterior descending trifurcation lesion treated with three Taxus stents. Presented at TCTMD.com
5. Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005;111:791-795. (Pubitemid 40250640)
6. Shammas NW, Dippel EJ, Avila A, et al. Long-term outcomes in treating left main trifurcation coronary artery disease with the paclitaxel-eluting stent. J Invasive Cardiol 2007;19:77-82.
7. Anselmino M, Biondi-Zoccai G, Moretti C, Sheiban I. Percutaneous coronary intervention on left main coronary artery trifurcation. Heart Vessels 2008;23:279-281.
8. Furuichi S, Sangiorgi GM, Palloshi A, et al. Drug-eluting stent implantation in coronary trifurcation lesions. J Invasive Cardiol 2007;19:157-162 (Pubitemid 46557997)
9. Alizadehranjbar K, Brass N, Cheung P, et al. Successful treatment of trifurcation and quadrifurcation lesions using a minimal protrusion balloon crush technique. J Interv Cardiol 2008;21:21-27. (Pubitemid 351192884)
10. Shammas NW. Trifurcation coronary artery disease: A proposed classification and treatment methodology. J Invasive Cardiol 2007;19:32-35. (Pubitemid 46088070)
11. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A consensus document of the the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502-1513.
12. Serruys PW, Daemen J. Late stent thrombosis: A nuisance in both bare metal and drug-eluting stents. Circulation 2007;115:1433-1439. (Pubitemid 46648379)
13. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimuseluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-1249. (Pubitemid 38372783)
14. Azzarelli S, Amico F, Galassi AR, et al. Two-year clinical follow up of coronary drugeluting stent in patients at high risk for coronary restenosis. J Invasive Cardiol 2008;20:62-66. (Pubitemid 351271443)
15. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxeleluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-1223. (Pubitemid 41352109)
16. Lemos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004;109:1366-1370. (Pubitemid 38387822)
17. Abizaid A, Chan C, Lim YT, et al. Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM registry). Am J Cardiol 2006;98:1028-1032. (Pubitemid 44486137)
18. Sharis PJ, Voelliger CM, Ahuja A, et al. Large single center experience with unprotected left main coronary artery drug-eluting stenting in 289 patients. Presented at New Cardiovascular Horizons, September 2008, abstract #2, New Orleans, Louisianna.
19. Mohr EF. SYNTAX trial end points in 3VD subset. TCT 2008; October 14, 2008; Washington, D.C
20. Serruys P. SYNTAX trial end points in left main subset. TCT 2008; October 14, 2008; Washington, D.C.